A biopsy of financial conflicts of interest in medicine

Surgery

Volumn 143, Issue 2, 2008, Pages 193-198

  Stossel, Thomas P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CONFLICT OF INTEREST; ECONOMIC ASPECT; EDITORIAL; MEDICINE; PRIORITY JOURNAL; SURGEON; UNIVERSITY;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; FINANCIAL SUPPORT; HUMANS; SURGICAL PROCEDURES, OPERATIVE;

EID: 38649133309     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.11.013     Document Type: Editorial

References (32)

1. Ford E., Ajani U., Croft J., et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 356 (2007) 2388-2398
2. Schacht W. The Bayh-Dole act: selected issues in patent policy and the commercialization of technology (2006), Congressional Research Service, Washington (DC)
3. Starr A., and Edwards M. Mitral replacement: the shielded ball valve prosthesis. J Thorac Cardiovasc Surg 42 (1961) 673-682
4. Starr D. Blood: an epic history of medicine and commerce (1998), Alfred A Knopf, New York (NY) p. 180-1
5. Stossel T. Regulating academic-industry research relationships-solving problems or stifling progress. N Engl J Med 353 (2005) 1060-1065
6. Stossel T. Regulation of financial conflicts of interest in medical practice and medical research: a damaging solution in search of a problem. Perspect Biol Med 50 (2007) 54-71
7. Lurie P., Almeida C., Stine N., Stine A., and Wolfe S. Financial conflict of interest disclosure and voting patterns at food and drug administration drug advisory committee meetings. JAMA 295 (2006) 1921-1928
8. Beamish R. NIH's new ethics rules lead some to ponder jumping ship. Washington Post (2006) October 30
9. National Institutes of Health. Evaluation of the impact of the new NIH ethics rules on recruitment and retention. Available at: http://www.nih.gov/about/ethics_COI.htm. Accessed October 26, 2006.
10. DeAngelis C. The influence of money on medical science. JAMA 296 (2006) 996-998
11. Laine C., Goodman S., Griswold M., and Sox H. Reproducible research: moving toward research the public can really trust. Ann Int Med 146 (2007) 450-453
12. Angell M. Is academic medicine for sale?. N Engl J Med 342 (2000) 1516-1518
13. Azoulay P., Michigan R., and Sampat B.N. The anatomy of medical school patenting. N Engl J Med (2007) 2049-2056
14. Hoffmeister K., Josefsson E., Isaac N., Clausen H., Hartwig J., and Stossel T. Glycosylation restores survival of chilled blood platelets. Science 301 (2003) 1531-1534
15. Polanyi M. Personal knowledge. Towards a post-critical philosophy (1958), University of Chicago Press, Chicago
16. Campbell E., Gruen R., Mountford J., Miller L., Cleary P., and Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 356 (2007) 1742-1750
17. Angell M. The truth about the drug companies: how they deceive us and what to do about it (2004), Random House, New York
18. Kassirer J. On the take. how medicine's complicity with big business can endanger your health (2004), Oxford University Press, Oxford, England
19. Psaty B., and Burke S. Protecting the health of the public-Institute of Medicine recommendations on drug safety. N Engl J Med 355 (2006) 1753-1755
20. Brennan T., Rothman D., Blank L., et al. Health industry practices that create conflict of interest. A policy proposal for academic medical centers. JAMA 295 (2006) 429-433
21. Marks H. The progress of experiment. science and therapeutic reform in the United States, 1900-1990 (1997), Oxford University Press, Oxford, England
22. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift. JAMA 283 (2000) 373-380
23. Epstein R. Overdose. How excessive government regulation stifles pharmaceutical innovation (2006), Yale University Press, New Haven, CT
24. Cohen J., Cabanilla L., and Sosnov J. Role of follow-on drugs and indications on the WHO essential drug list. J Clin Pharm Ther 31 (2006) 585-592
25. Majumdar S., McAlister F., and Soumerai S. Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States. Am J Med 115 (2003) 467-472
26. Research!America. National survey 2004. Charleton Company for Research!America. Available at: http://www.researchamerica.org/polldtat/index.html. Accessed August 25, 2005.
27. Hampson L., Agrawal M., Joffe S., Gross C., Vertrer J., and Emanuel E. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med 355 (2006) 2330-2337
28. Jacobs J. Systems of survival (1992), Vintage, New York
29. Gawande A. Piece work. Medicine's money problem. The New Yorker April 4, 2005. p. 1-5.
30. Schumpeter J.A. Capitalism, Socialism and Democracy (1950), Harper Torchbooks, New York (NY)
31. Hayek F. The fatal conceit (1988), University of Chicago Press, Chicago
32. Muller J.Z. The democratic threat to free markets. Daedalus 136 (2007) 77-86